orciprenaline [6019]
orciprenaline
| SMILES | CC(C)NCC(O)c1cc(O)cc(O)c1 |
| InChIKey | LMOINURANNBYCM-UHFFFAOYSA-N |
Chemical Properties
| Hydrogen bond acceptors | 4 |
| Hydrogen bond donors | 4 |
| Rotatable bonds | 4 |
| Log P | 1.129 |
| Molecular weight (Da) | 211.1 |
| Stereochemistry info | unspecified |
Database connections
| Ligand site mutations | β2 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
orciprenaline
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
| Ligand site mutations | β2 |